WNRC Wenr Corporation (CE)

WENR Corp. (OTC:WNRC) (wenr.net), announced today that it has signed a letter of intent to merge with St. Paul Pharmaceutical, a Puerto Rican based company. The parties anticipate closing within 90 days. Terms were not disclosed. St. Paul Pharmaceutical, Inc., is incorporated in Puerto Rico and authorized to do business in California. It has operations in Garden Grove, California, Vancouver, British Columbia and also Viet Nam. St. Paul is a pharmaceutical company that specializes in the manufacture and distribution of generic pharmaceuticals, generic over-the-counter pharmaceuticals and vitamin supplements. WENR Corporation is a holding company that acquires technology and technology companies. It provides senior management assistance for product and market development and secures working capital. The foregoing contains forward-looking information within the meaning of The Private Securities Litigation Act of 1995. Such forward-looking statements involve certain risks and uncertainties. The actual results may differ materially from such forward-looking statements. The company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results (expressed or implied) will not be realized.